KLRS — Kalaris Therapeutics Share News
0.000.00%
Last trade - 00:00U.S. RESEARCH ROUNDUP- Constellation Brands, Northern Trust, Roper Technologies
U.S. STOCKS ON THE MOVE-Mosaic, Eli Lilly, I-Mab
U.S. STOCKS ON THE MOVE-Cidara Therapeutics, Crown Crafts, iRobot
U.S. STOCKS ON THE MOVE-NRG Energy, GMS, Dow
U.S. STOCKS ON THE MOVE-Root, Tesla, Darden Restaurants
AlloVir tumbles on pricing $75 mln stock offering
Brief: Allovir Announces Pricing Of Public Offering Of Common Stock
Brief: Allovir Inc Notifies SVB Securities That It Was Terminating Prospectus Supplement
Cell therapy firm AlloVir tumbles on stock offering
Brief: AlloVir Announces Proposed Public Offering Of Common Stock
Brief: AlloVir Presents Final Results From Phase 2 Trial Of Posoleucel Treatment At ATC 2023
Allovir Inc reports results for the quarter ended in March - Earnings Summary
Brief: Allovir Reports First Quarter 2023 Financial Results
Allovir Inc expected to post a loss of 46 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Hoth Therapeutics, Activision Blizzard, Getaround
AlloVir rises on positive data for lead cell therapy
Brief: Allovir Announces Positive Results
Brief: Allovir Inc Files For Stock Shelf Of Up To 31.4 Million Shares Of Common Stock By Selling Shareholders - SEC Filing
Allovir Inc reports results for the quarter ended in December - Earnings Summary